Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Chak-Lui Wong

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Trends in Molecular Medicine|July 1, 2026
Targeting amino acid metabolism in hepatocellular carcinomaYibing Wu, Carmen Chak-Lui Wong
Hepatology Communications|September 3, 2024
The mechanistic insights behind the anticancer effects of statins in liver cancerYiling Chen, Carmen Chak-Lui Wong
Molecular & Cellular Oncology|December 7, 2017
The folate cycle is a new metabolic weakness of cancerDerek Lee, Carmen Chak-Lui Wong
Hepatology (Baltimore, Md.)|March 19, 2025
CAD-driven pathways in HCC metastasisCarmen Chak-Lui Wong, Chun-Ming Wong
Antioxidants & Redox Signaling|May 11, 2022
Role of Metabolism in Adoptive T Cell Therapy: Strategies and ChallengesGe Hui Tan, Carmen Chak-Lui Wong
Hepatology Communications|March 17, 2023
The future of Hepatology CommunicationsElliot B Tapper, Carmen Chak-Lui Wong
Clinical and Molecular Hepatology|October 14, 2025
Stratifying Cholangiocarcinoma: Tumor Microenvironment, Molecular Drivers, and Novel Immunotherapeutic ApproachesCindy Xinqi Liu, Carmen Chak-Lui Wong
Gut|March 27, 2025
ETV5-S100A9 feed-forward loop connecting HCC and MDSCs to shape the immunosuppressive tumour microenvironmentCarmen Chak-Lui Wong, Chun Ming Wong
The Journal of Clinical Investigation|August 5, 2020
Hypoxia-inducible factors and innate immunity in liver cancerVincent Wai-Hin Yuen, Carmen Chak-Lui Wong
Hepatology (Baltimore, Md.)|April 3, 2021
Mechanistic Rationales Guiding Combination Hepatocellular Carcinoma Therapies Involving Immune Checkpoint InhibitorsJacinth Wing-Sum Cheu, Carmen Chak-Lui Wong
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Trends in Molecular Medicine|July 1, 2026
Targeting amino acid metabolism in hepatocellular carcinomaYibing Wu, Carmen Chak-Lui Wong
Hepatology Communications|September 3, 2024
The mechanistic insights behind the anticancer effects of statins in liver cancerYiling Chen, Carmen Chak-Lui Wong
Molecular & Cellular Oncology|December 7, 2017
The folate cycle is a new metabolic weakness of cancerDerek Lee, Carmen Chak-Lui Wong
Hepatology (Baltimore, Md.)|March 19, 2025
CAD-driven pathways in HCC metastasisCarmen Chak-Lui Wong, Chun-Ming Wong
Antioxidants & Redox Signaling|May 11, 2022
Role of Metabolism in Adoptive T Cell Therapy: Strategies and ChallengesGe Hui Tan, Carmen Chak-Lui Wong
Hepatology Communications|March 17, 2023
The future of Hepatology CommunicationsElliot B Tapper, Carmen Chak-Lui Wong
Clinical and Molecular Hepatology|October 14, 2025
Stratifying Cholangiocarcinoma: Tumor Microenvironment, Molecular Drivers, and Novel Immunotherapeutic ApproachesCindy Xinqi Liu, Carmen Chak-Lui Wong
Gut|March 27, 2025
ETV5-S100A9 feed-forward loop connecting HCC and MDSCs to shape the immunosuppressive tumour microenvironmentCarmen Chak-Lui Wong, Chun Ming Wong
The Journal of Clinical Investigation|August 5, 2020
Hypoxia-inducible factors and innate immunity in liver cancerVincent Wai-Hin Yuen, Carmen Chak-Lui Wong
Hepatology (Baltimore, Md.)|April 3, 2021
Mechanistic Rationales Guiding Combination Hepatocellular Carcinoma Therapies Involving Immune Checkpoint InhibitorsJacinth Wing-Sum Cheu, Carmen Chak-Lui Wong
Pageof 10